Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) ... Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural, and biosecurity applications. The company offers Group B Streptococcus (GBS) rapid sensor, a diagnostic for the detection of human GBS in expectant mothers; kidney diseases, a POC tests for the screening, detection, and ongoing monitoring of various subsets of acute kidney injury and chronic kidney disease; bovine mastitis, a farm diagnostic to detect mastitis early which helps farmers; biosecurity pathogen tests, a portable sensor for frontline detection of invasive pests and pathogens -built for customs officers, farmers, and quarantine zones. The company was incorporated in 2021 and is based in Sydney, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.04 | 17.7777777778 | 0.225 | 0.265 | 0.215 | 186360 | 0.24025303 | DE |
| 4 | 0.035 | 15.2173913043 | 0.23 | 0.265 | 0.21 | 180690 | 0.24000838 | DE |
| 12 | 0.08 | 43.2432432432 | 0.185 | 0.29 | 0.175 | 391258 | 0.22001382 | DE |
| 26 | 0.1 | 60.6060606061 | 0.165 | 0.29 | 0.14 | 396953 | 0.19872321 | DE |
| 52 | -0.02 | -7.01754385965 | 0.285 | 0.315 | 0.13 | 441939 | 0.21149393 | DE |
| 156 | -0.02 | -7.01754385965 | 0.285 | 0.315 | 0.13 | 441939 | 0.21149393 | DE |
| 260 | -0.02 | -7.01754385965 | 0.285 | 0.315 | 0.13 | 441939 | 0.21149393 | DE |
Dodger1
4分前
IHuser
11分前
StocktonCA
14分前
Dodger1
17分前
EternalPatience
19分前
gdl
20分前
3331
25分前
Stock Guy777
29分前
LOB
33分前
diamondguru-one
34分前
BigB111
40分前
novascotiaSTS
40分前
Split T
41分前
F14SVF24
42分前
gfp927z
42分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。